Udd KA - Search Results

1

Risk of skin cancer in multiple myeloma patients: a retrospective cohort study.

Robinson AA, Wang J, Vardanyan S, Madden EK, Hebroni F, Udd KA, Spektor TM, Nosrati JD, Kitto AZ, Zahab M, Cheema S, Fors DH, Norberg A, Diehl J, Waterman GN, Swift RA, Crowley J, Berenson JR. Robinson AA, et al. Among authors: udd ka. Eur J Haematol. 2016 Nov;97(5):439-444. doi: 10.1111/ejh.12748. Epub 2016 Mar 7. Eur J Haematol. 2016. PMID: 26872804

2

Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients.

Ghermezi M, Li M, Vardanyan S, Harutyunyan NM, Gottlieb J, Berenson A, Spektor TM, Andreu-Vieyra C, Petraki S, Sanchez E, Udd K, Wang CS, Swift RA, Chen H, Berenson JR. Ghermezi M, et al. Haematologica. 2017 Apr;102(4):785-795. doi: 10.3324/haematol.2016.150896. Epub 2016 Dec 29. Haematologica. 2017. PMID: 28034989 Free PMC article.

3

Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy.

Wang J, Udd KA, Vidisheva A, Swift RA, Spektor TM, Bravin E, Ibrahim E, Treisman J, Masri M, Berenson JR. Wang J, et al. Among authors: udd ka. Support Care Cancer. 2016 Jul;24(7):3105-10. doi: 10.1007/s00520-016-3126-1. Epub 2016 Feb 23. Support Care Cancer. 2016. PMID: 26902977

4

Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic.

Berenson A, Vardanyan S, David M, Wang J, Harutyunyan NM, Gottlieb J, Halleluyan R, Spektor TM, Udd KA, Eshaghian S, Nassir Y, Eades B, Swift R, Berenson JR. Berenson A, et al. Among authors: udd ka. Ann Hematol. 2017 Mar;96(3):441-448. doi: 10.1007/s00277-016-2888-3. Epub 2016 Dec 2. Ann Hematol. 2017. PMID: 27913860

5

Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib.

Berenson A, Vardanyan S, David M, Wang J, Harutyunyan NM, Gottlieb J, Halleluyan R, Spektor TM, Udd KA, Eshaghian S, Nassir Y, Eades B, Swift R, Berenson JR. Berenson A, et al. Among authors: udd ka. Ann Hematol. 2017 Mar;96(3):449-459. doi: 10.1007/s00277-016-2889-2. Epub 2016 Dec 8. Ann Hematol. 2017. PMID: 27933373

6

Monitoring multiple myeloma.

Udd KA, Spektor TM, Berenson JR. Udd KA, et al. Clin Adv Hematol Oncol. 2017 Dec;15(12):951-961. Clin Adv Hematol Oncol. 2017. PMID: 29315287

7

Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study.

Gross Z, Rahbari A, Wirtschafter E, Spektor TM, Udd KA, Bujarski S, Ghermezi M, Nosrati JD, Vidisheva A, Eades B, Cecchi G, Maluso T, Swift R, Berenson JR. Gross Z, et al. Among authors: udd ka. Eur J Haematol. 2018 Jun;100(6):621-623. doi: 10.1111/ejh.13058. Epub 2018 Apr 25. Eur J Haematol. 2018. PMID: 29524348

8

Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells.

Chen H, Li M, Xu N, Ng N, Sanchez E, Soof CM, Patil S, Udd K, Bujarski S, Cao J, Hekmati T, Ghermezi M, Zhou M, Wang EY, Tanenbaum EJ, Zahab B, Schlossberg R, Yashar MA, Wang CS, Tang GY, Spektor TM, Berenson JR. Chen H, et al. Leuk Res. 2019 Jun;81:62-66. doi: 10.1016/j.leukres.2019.04.008. Epub 2019 Apr 18. Leuk Res. 2019. PMID: 31035033

9

Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy.

Bujarski S, Udd K, Soof C, Chen H, Spektor TM, Safaie T, Li M, Stern J, Wang C, Xu N, Emamy-Sadr M, Swift R, Rahbari A, Patil S, Souther E, Regidor B, Sutanto C, Berenson JR. Bujarski S, et al. Target Oncol. 2021 Jul;16(4):503-515. doi: 10.1007/s11523-021-00821-6. Epub 2021 Jun 7. Target Oncol. 2021. PMID: 34097243

10

Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.

Vidisheva AP, Wang J, Spektor TM, Bitran JD, Lutzky J, Tabbara IA, Ye JZ, Ailawadhi S, Stampleman LV, Steis RG, Moezi MM, Swift RA, Maluso TM, Udd KA, Eshaghian S, Nassir Y, Berenson JR. Vidisheva AP, et al. Among authors: udd ka. Support Care Cancer. 2017 Oct;25(10):3217-3224. doi: 10.1007/s00520-017-3732-6. Epub 2017 Apr 28. Support Care Cancer. 2017. PMID: 28455546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters